Ifp Advisors, Inc Brainstorm Cell Therapeutics Inc. Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$1.37 - $4.42 $3,014 - $9,724	-2,200 Reduced 7.63%	26,650 $139,000
Q3 2022 Nov 08, 2022	BUY	$2.55 - $4.42 $22,950 - $39,780	9,000 Added 45.34%	28,850 $151,000
Q2 2022 Sep 06, 2022	BUY	$2.71 - $3.6 $53,793 - $71,460	19,850 New	19,850 $104,000
Q2 2022 Aug 12, 2022	SELL	$2.71 - $3.6 $53,793 - $71,460	-19,850 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$2.92 - $4.19 $57,962 - $83,171	19,850 New	19,850 $66,000
Q3 2021 Oct 06, 2021	SELL	$3.14 - $4.09 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$3.01 - $4.01 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$3.46 - $7.88 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$3.99 - $17.73 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$11.19 - $16.92 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$4.42 - $12.66 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$4.01 - $8.88 $0 - $0	0 New	0 $0

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.